First, second kidney transplants have similar success: study

(HealthDay) -- One failed kidney transplant doesn't mean a second transplant is likely to fail, according to a new study that found similar kidney survival, rejection and infection rates in people who undergo repeat transplants compared to patients who have had just one.

"Second transplants have traditionally been considered a high immunologic risk, but there's been a lack of data on outcomes of re-transplants," said the study's leader, Dr. Syed Jawad Sher, at the Indiana University School of Medicine, in a National Kidney Foundation news release. "Our study, which was controlled for donor factors making the findings reliable, shows that re-transplants can be equally successful."

The researchers examined 38 cases where one kidney of a deceased donor was transplanted into a patient receiving a primary transplant, and the other was donated to a patient receiving a repeat transplant.

One- and five-year kidney graft survival rates were similar, according to the researchers, who also found no differences in the rate of bacterial or . Advances in medications to suppress the might be responsible for increasing success of repeat transplants, Sher said.

"The message to kidney specialists is that they can feel comfortable referring patients with failed transplants for a second evaluation. This study also gives hope to patients that they have a very good likelihood of success the second time around," said Dr. Lynda Szczech, president of the , in the release.

The study's findings were expected to be presented Thursday at the foundation's annual meeting, in Washington, D.C. The data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.

More information: The U.S. National Institutes of Health provides more information on kidney transplants.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Ebola scare boosts business for US company

50 minutes ago

The Ebola scare has subsided in the United States, at least temporarily, but an Alabama manufacturer is still trying to catch up with a glut of orders for gear to protect against the disease.

Thai parliament votes to ban commercial surrogacy (Update)

8 hours ago

Thailand's parliament has voted to ban commercial surrogacy after outrage erupted over the unregulated industry following a series scandals including the case of an Australian couple accused of abandoning a baby with Down's ...

Doctor behind 'free radical' aging theory dies

Nov 25, 2014

Dr. Denham Harman, a renowned scientist who developed the most widely accepted theory on aging that's now used to study cancer, Alzheimer's disease and other illnesses, has died in Nebraska at age 98.

Mexican boy who had massive tumor recovering

Nov 25, 2014

An 11-year-old Mexican boy who had pieces of a massive tumor removed and who drew international attention after U.S. officials helped him get treatment in the southwestern U.S. state of New Mexico is still recovering after ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.